PNTG · Pennant Group, Inc. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-10 | SMITH BARRY M |
Director |
Gift↓
|
Common Stock
|
5,100 |
| 2026-10-23 | Gochnour John J |
Chief Operating Officer |
Convert↑
|
Common Stock
|
5,948 |
| 2026-10-23 | Gochnour John J |
Chief Operating Officer |
Tax↓
|
Common Stock
|
6,624 |
| 2026-10-23 | Gochnour John J |
Chief Operating Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Options assumed on October 1, 2019 by the Registrant under The Ensign Group, Inc. 2007 Omnibus Incentive Plan as a result of the Spin-off. 5,030 of these options have vested. 2,514 of these options vested on October 26, 2019, 2,514 of these options vested on October 26, 2020 and 2,514 of these options vested on October 26, 2021. |
Stock Option (right to buy)
|
5,948 |
| 2026-10-15 | Lamb Scott E |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning October 15, 2027. |
Common Stock
|
2,400 |
| 2026-10-15 | Nackel John G. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning October 15, 2027. |
Common Stock
|
1,900 |
| 2026-10-15 | SMITH BARRY M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning October 15, 2027. |
Common Stock
|
1,900 |
| 2026-10-15 | Christensen Christopher R. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning October 15, 2027. |
Common Stock
|
1,900 |
| 2026-10-15 | COVEY STEPHEN M R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning October 15, 2027. |
Common Stock
|
1,900 |
| 2026-10-15 | Morris Gregory K Sr. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning October 15, 2027. |
Common Stock
|
1,900 |
| 2026-10-15 | Snapper Suzanne D. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning October 15, 2027. |
Common Stock
|
1,900 |
| 2026-08-06 | Steik Jason Paul |
Chief Clinical Officer |
Sell↓
|
Common Stock
|
1,394 |
| 2026-08-06 | Guerisoli Brent |
Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 |
Common Stock
|
4,285 |
| 2026-08-06 | Cheney Kirk Sterling |
EVP, GC and Corp Secy |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 26, 2022 |
Common Stock
|
1,393 |
| 2026-07-15 | Nackel John G. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning July 15, 2027. |
Common Stock
|
1,900 |
| 2026-07-15 | Lamb Scott E |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning July 15, 2027. |
Common Stock
|
2,400 |
| 2026-07-15 | Morris Gregory K Sr. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning July 15, 2027. |
Common Stock
|
1,900 |
| 2026-07-15 | Christensen Christopher R. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning July 15, 2027. |
Common Stock
|
1,900 |
| 2026-07-15 | SMITH BARRY M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning July 15, 2027. |
Common Stock
|
1,900 |
| 2026-07-15 | Snapper Suzanne D. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning July 15, 2027. |
Common Stock
|
1,900 |
| 2026-07-15 | COVEY STEPHEN M R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning July 15, 2027. |
Common Stock
|
1,900 |
| 2026-07-10 | Guerisoli Brent |
Chief Executive Officer |
Convert↑
|
Common Stock
|
6,248 |
| 2026-07-10 | Guerisoli Brent |
Chief Executive Officer |
Sell↓
|
Common Stock
|
3,159 |
| 2026-07-10 | Guerisoli Brent |
Chief Executive Officer |
Convert↓
|
Stock Option (right to buy)
|
6,248 |
| 2026-07-07 | Guerisoli Brent |
Chief Executive Officer |
Sell↓
|
Common Stock
|
3,165 |
| 2026-07-07 | Guerisoli Brent |
Chief Executive Officer |
Convert↑
|
Common Stock
|
6,249 |
| 2026-07-07 | Guerisoli Brent |
Chief Executive Officer |
Convert↓
|
Stock Option (right to buy)
|
6,249 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Convert↑
|
Common Stock
|
4,463 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Sell↓
|
Common Stock
|
2,254 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Convert↑
|
Common Stock
|
4,463 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at price of $35.10. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares executed at each separate price. |
Common Stock
|
200 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at price of $35.08. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares executed at each separate price. |
Common Stock
|
2,032 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Sell↓
|
Common Stock
|
22 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Convert↓
|
Stock Option (right to buy)
|
4,463 |
| 2026-05-22 | Guerisoli Brent |
Chief Executive Officer |
Convert↓
|
Stock Option (right to buy)
|
4,463 |
| 2026-04-15 | SMITH BARRY M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning April 15, 2027. |
Common Stock
|
1,900 |
| 2026-04-15 | Nackel John G. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning April 15, 2027. |
Common Stock
|
1,900 |
| 2026-04-15 | COVEY STEPHEN M R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning April 15, 2027. |
Common Stock
|
1,900 |
| 2026-04-15 | Morris Gregory K Sr. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning April 15, 2027. |
Common Stock
|
1,900 |
| 2026-04-15 | Christensen Christopher R. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning April 15, 2027. |
Common Stock
|
1,900 |
| 2026-04-15 | Snapper Suzanne D. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning April 15, 2027. |
Common Stock
|
1,900 |
| 2026-04-15 | Lamb Scott E |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest in three annual installments beginning April 15, 2027. |
Common Stock
|
2,400 |
| 2026-03-05 | Cheney Kirk Sterling |
EVP, GC and Corp Secy |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These shares vest in five equal annual installments beginning March 5, 2027. |
Stock Option (right to buy)
|
30,000 |
| 2026-03-05 | Guerisoli Brent |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These shares vest in five equal annual installments beginning March 5, 2027. |
Stock Option (right to buy)
|
45,000 |
| 2026-03-05 | Walbom Lynette |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These shares vest in five equal annual installments beginning March 5, 2027. |
Stock Option (right to buy)
|
34,000 |
| 2026-03-05 | Gochnour John J |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These shares vest in five equal annual installments beginning March 5, 2027. |
Stock Option (right to buy)
|
41,000 |
| 2026-03-05 | Steik Jason Paul |
Chief Clinical Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These shares vest in five equal annual installments beginning March 5, 2027. |
Stock Option (right to buy)
|
26,000 |
| 2026-03-03 | Guerisoli Brent |
Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest immediately on March 3, 2026. This amendment is being filed to correct the amount of securities beneficially owned as of the transaction date reported above. |
Common Stock
|
11,260 |
| 2026-03-03 | Cheney Kirk Sterling |
EVP, GC and Corp Secy |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest immediately on March 3, 2026. This amendment is being filed to correct the amount of securities beneficially owned as of the transaction date reported above. |
Common Stock
|
2,874 |
| 2026-03-03 | Walbom Lynette |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest immediately on March 3, 2026. This amendment is being filed to correct the amount of securities beneficially owned as of the transaction date reported above. |
Common Stock
|
8,025 |